Structural and Biomechanical Corneal Differences between Type 2 Diabetic and Nondiabetic Patients
Table 3
Subgroup analysis of diabetic patients.
Age (y)
Female (n)
DM duration (y)
HbA1c (%)
DR presence (n)
CCTa (μm)
IOPcc (mmHg)
CH (mmHg)
CRF (mmHg)
Duration of diabetes (y)
<10 ()
73.30 ± 5.51
18 (60%)
4.90 ± 2.37
6.64 ± 0.75
4 (13%)
556.73 ± 38.15
16.41 ± 3.23
9.92 ± 1.29
9.96 ± 1.54
≥10 ()
71.47 ± 5.75
20 (67%)
17.07 ± 7.00
7.41 ± 1.32
14 (47%)
558.77 ± 31.54
16.16 ± 3.39
10.49 ± 1.57
10.57 ± 1.38
HbA1c levels (%)
<7.0 ()
72.90 ± 5.21
18 (58%)
7.58 ± 5.75
6.20 ± 0.47
5 (16%)
553.74 ± 39.15
16.16 ± 3.50
10.02 ± 1.57
9.99 ± 1.49
≥7.0 ()
71.83 ± 6.15
20 (69%)
14.62 ± 8.60
7.91 ± 0.95
13 (45%)
562.03 ± 29.33
16.42 ± 3.10
10.40 ± 1.32
10.56 ± 1.46
DR stage
No ()
72.95 ± 5.66
27 (64%)
8.38 ± 6.09
6.85 ± 1.05
—
555.69 ± 36.16
16.76 ± 3.35
10.07 ± 1.48
10.26 ± 1.62
Yes ()
71.06 ± 5.58
11 (61%)
17.06 ± 8.87
7.42 ± 1.26
562.56 ± 31.53
15.17 ± 2.92
10.52 ± 1.37
10.27 ± 1.15
Continuous variables are reported as mean ± standard deviation. represents statistical significance. aCCT measured by using Pentacam at corneal vertex. CCT, central corneal thickness; K, keratometry; mm, millimeters; n/a, not applicable; WS, waveform score; y, years; μm, micrometer.
